{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013823","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.167222+00:00","generated_at":"2026-05-19T22:44:57.358593+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Dermata Therapeutics changes auditor to Baker Tilly after Moss Adams merger","bullets":["Moss Adams merged into Baker Tilly US, LLP effective June 3, 2025; audit committee approved Baker Tilly as successor.","No disagreements with Moss Adams on accounting principles or audit scope for FY2024, FY2023, or interim period.","Prior audit reports included a going concern uncertainty paragraph; no adverse or modified opinions.","Moss Adams provided a letter agreeing with the statements, filed as Exhibit 16.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013823","json":"https://secwatch.observer/filing/0001641172-25-013823.json","markdown":"https://secwatch.observer/filing/0001641172-25-013823.md","text":"https://secwatch.observer/filing/0001641172-25-013823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225013823/0001641172-25-013823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225013823/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:44:57.358593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"987fddb756d2cc6ab555a5d9e6f6edc782b60e48","claim":"Dermata Therapeutics, Inc. engaged Baker Tilly US, LLP as its auditor.","evidence_excerpt":"In connection with the notification of the merger, the audit committee of the Company’s Board of Directors approved the appointment of Baker Tilly, as the successor to Moss Adams, as the Company’s independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225013823/0001641172-25-013823-index.htm","confidence":0.95,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Baker Tilly US, LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}